Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Wenxin Decoction is a traditional Chinese medicine (TCM) herbal formula historically used for the treatment of cardiovascular diseases, particularly spontaneous angina pectoris (SAP). The decoction is composed of several herbs and has been shown in clinical studies to improve symptoms and electrocardiographic findings in patients with SAP. Its mechanism appears to involve improving myocardial ischemia by modulating metabolic pathways such as arachidonic acid metabolism, glycerophospholipid metabolism, lysine degradation, and tyrosine metabolism. Key active constituents identified include ginsenoside Rb1, cinnamic acid, paeoniflorin, and berberine. The formula is not a single chemical entity but a multi-herbal combination typical of TCM practice[6][8].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Wenxin Decoction.